An ontology for description of drug discovery investigations

Da Qi, Ross D. King, Andrew L. Hopkins, G. Richard J. Bickerton, Larisa N. Soldatova (Lead / Corresponding author)

    Research output: Contribution to journalArticlepeer-review

    31 Citations (Scopus)


    The paper presents an ontology for the description of Drug Discovery Investigation (DDI).This has been developed through the use of a Robot Scientist "Eve", and in consultation with industry. DDI aims to define the principle entities and the relations in the research and development phase of the drug discovery pipeline. DDI is highly transferable and extendable due to its adherence to accepted standards, and compliance with existing ontology resources. This enables DDI to be integrated with such related ontologies as the Vaccine Ontology, the Advancing Clinico-Genomic Trials on Cancer Master Ontology, etc. DDI is available at or
    Original languageEnglish
    Article number126
    Number of pages13
    JournalJournal of Integrative Bioinformatics
    Issue number3
    Publication statusPublished - 2010


    Dive into the research topics of 'An ontology for description of drug discovery investigations'. Together they form a unique fingerprint.

    Cite this